Testing a treatment to improve bone strength in children with osteogenesis imperfecta
Official title: Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta
Funded at University of Missouri-Columbia · NIH-10840238 · Data updated 2026-11-12
This study is looking at a new treatment that could help make bones stronger in kids with osteogenesis imperfecta (OI) by blocking a protein that stops muscle growth, starting from a young age to see if it can improve their bone health and overall well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $217,371 |
| NIH project number | 1R56HD110848-01 |
| Project ID | NIH-10840238 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are infants and young children diagnosed with osteogenesis imperfecta.
✕Less likely to help
Patients with osteogenesis imperfecta who are older or have already undergone significant treatment may not benefit from this early life intervention.
What this research studies
This research investigates a new therapy aimed at enhancing bone strength in children with osteogenesis imperfecta (OI), a genetic disorder that leads to fragile bones and muscle weakness. The approach involves inhibiting myostatin, a protein that limits muscle growth, starting from early life to potentially improve bone density and overall health. By using animal models, the researchers aim to understand how early intervention can lead to better outcomes for children affected by this condition. The study builds on previous findings that suggest early myostatin inhibition can significantly enhance bone quality.
Why it matters
Potential benefit: If successful, this research could lead to a novel treatment that significantly improves bone strength and reduces the risk of fractures in children with osteogenesis imperfecta.
How similar studies have gone: Previous studies have shown promising results with myostatin inhibition in animal models, indicating potential for success in this novel approach.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Phillips, Charlotte L — University of Missouri-Columbia
- Study coordinator: Phillips, Charlotte L
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.